CAM
Congress Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Buy |
68,404
+102
| +0.1% | +$4.96K | 0.02% | 253 |
|
|
2025
Q1 | $2.32M | Sell |
68,302
-437
| -0.6% | -$14.9K | 0.02% | 265 |
|
|
2024
Q4 | $2.71M | Buy |
68,739
+2,971
| +5% | +$117K | 0.02% | 267 |
|
|
2024
Q3 | $3.09M | Buy |
65,768
+1,788
| +3% | +$84K | 0.02% | 255 |
|
|
2024
Q2 | $3.46M | Sell |
63,980
-625
| -1% | -$33.8K | 0.02% | 249 |
|
|
2024
Q1 | $4.4M | Buy |
64,605
+24,303
| +60% | +$1.66M | 0.03% | 231 |
|
|
2023
Q4 | $2.52M | Buy |
40,302
+42
| +0.1% | +$2.63K | 0.02% | 283 |
|
|
2023
Q3 | $1.83M | Buy |
+40,260
| New | +$1.83M | 0.02% | 282 |
|
|
2021
Q1 | – | Sell |
-16,695
| Closed | -$2.56M | – | 358 |
|
|
2020
Q4 | $2.56M | Buy |
16,695
+170
| +1% | +$26K | 0.02% | 228 |
|
|
2020
Q3 | $1.38M | Hold |
16,525
| – | – | 0.02% | 243 |
|
|
2020
Q2 | $1.21M | Buy |
16,525
+375
| +2% | +$27.5K | 0.01% | 250 |
|
|
2020
Q1 | $685K | Hold |
16,150
| – | – | 0.01% | 272 |
|
|
2019
Q4 | $984K | Sell |
16,150
-26,940
| -63% | -$1.64M | 0.01% | 281 |
|
|
2019
Q3 | $1.77M | Hold |
43,090
| – | – | 0.02% | 262 |
|
|
2019
Q2 | $2.03M | Buy |
43,090
+23,530
| +120% | +$1.11M | 0.03% | 269 |
|
|
2019
Q1 | $699K | Buy |
+19,560
| New | +$699K | 0.01% | 309 |
|